You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

Understanding and Addressing the Impact of Atopic Dermatitis in Children

Recognize the burden of pediatric atopic dermatitis and the effects of type 2 inflammation on skin barrier function - a short expert interview.

Antonella Muraro
Antonella Muraro

Learning objectives

  • Explore the impact of AD on children and their families/caregivers
  • Describe the approval and investigational status of therapeutic agents for the management of AD patients <12 years
  • Review available clinical trial safety and efficacy in children with AD <12 years (dupilumab)


In this ADVENT symposium at the 2022 EAACI congress, " The Next Frontier in Treatment of Atopic Dermatitis in Children”, Antonella Muraro, MD, PhD (Padua General University Hospital) and Andreas Wollenberg, MD, PhD (University of Munich) reviewed the impact of atopic dermatitis (AD) on pediatric patients and their caregivers, and the targeted therapeutic options for children with AD.

MAT-GLB-2202962 V2 07/2022

About this expert


Antonella Muraro


Consultant Pediatric Allergist at the Department of Pediatrics of the University of Padova, Italy

See author’s profile
Antonella Muraro

Related resources